{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:42:35Z","timestamp":1784698955753,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T-follicular helper (TFH) markers are expressed in the microenvironnement of marginal zone B-cell lymphoma (MZL), and in lymphomas arising from TFH-cells, sometimes making the differential diagnosis difficult. In the skin, the \u201cTFH-spectrum\u201d is poorly defined, going from primary cutaneous lymphoproliferative disorder with small\/medium CD4+\u2009T-cells (SMLPD) to cutaneous localizations of systemic angioimmunoblastic T-cell lymphoma (cAITL), and may pass through intermediate forms (primary cutaneous T-follicular helper derived lymphoma, not otherwise specified (PCTFHL,NOS)). We retrospectively analyzed 20 MZL, 13 SMLPD, 5 PCTFHL, and 11 cAITL clinically, histologically, and molecularly, to define tools to differentiate them. Characteristics that might favor the diagnosis of MZL over SMLPD are: multiple skin nodules (p\u2009&lt;\u20090.001), nodular architecture (p\u2009&lt;\u20090.01), residual germinal centers with follicular dendritic cell network (p\u2009&lt;\u20090.001), monotypic plasma cells (p\u2009&lt;\u20090.001), and few staining with PD1 (p\u2009=\u20090.016) or CXCL13 (p\u2009=\u20090.03). PCTFHL and cAITL presented as multiple (p\u2009&lt;\u20090.01) lesions, in older patients (p\u2009&lt;\u20090.01), with systemic symptoms and\/or biological alterations (p\u2009&lt;\u20090.01). Immunophenotypic loss of T-cell markers (p\u2009&lt;\u20090.001), BCL6 (p\u2009=\u20090.023) and\/or CD10 staining (p\u2009=\u20090.08), and a higher proliferative index (\u2265\u200930%, p\u2009=\u20090.039) favoured these diagnoses over SMLPD. Pathogenic variants were observed by genomic sequencing in 47% of MZL (<jats:italic>TNFAIP3<\/jats:italic> (32%), <jats:italic>EP300<\/jats:italic> (21%), <jats:italic>NOTCH2<\/jats:italic> (16%), <jats:italic>KMT2D<\/jats:italic> (16%), <jats:italic>CARD11<\/jats:italic> (10.5%)), 8% of SMLPD (<jats:italic>TET2<\/jats:italic>), 40% of PCTFHL (<jats:italic>SOCS1<\/jats:italic> (20%), <jats:italic>ARID1A<\/jats:italic> (20%)) and 64% of cAITL (<jats:italic>TET2<\/jats:italic> (63.6%), <jats:italic>RHOA<\/jats:italic> (36.4%), <jats:italic>NOTCH1<\/jats:italic> (9%)). This study characterizes the various clinical and histological features between cutaneous lymphomas expressing TFH markers and highlights the value of the interest of screening for genomic mutations in difficult cases.<\/jats:p>","DOI":"10.1038\/s41598-023-33031-3","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T18:25:07Z","timestamp":1682015107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Deciphering the spectrum of cutaneous lymphomas expressing TFH markers"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-5744","authenticated-orcid":false,"given":"Marie","family":"Donzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Trecourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Balme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Harou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Mauduit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Guesqui\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Perier-Muzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"33031_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze, R. et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 133, 1703\u20131714 (2019).","journal-title":"Blood"},{"key":"33031_CR2","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","volume":"26","author":"A Garcia-Herrera","year":"2008","unstructured":"Garcia-Herrera, A. et al. Primary cutaneous small\/medium CD4+ T-cell lymphomas: A heterogeneous group of tumors with different clinicopathologic features and outcome. J. Clin. Oncol. 26, 3364\u20133371 (2008).","journal-title":"J. Clin. Oncol."},{"key":"33031_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/cup.13475","volume":"46","author":"N Oishi","year":"2019","unstructured":"Oishi, N. et al. Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic features. J. Cutan. Pathol. 46, 637\u2013644 (2019).","journal-title":"J. Cutan. Pathol."},{"key":"33031_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2559.2010.03498.x","volume":"56","author":"A Le Tourneau","year":"2010","unstructured":"Le Tourneau, A. et al. Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases. Histopathology 56, 548\u2013551 (2010).","journal-title":"Histopathology"},{"key":"33031_CR5","doi-asserted-by":"publisher","first-page":"B70","DOI":"10.1016\/j.annder.2012.10.049","volume":"139","author":"N Ortonne","year":"2012","unstructured":"Ortonne, N. et al. Lymphomes T cutan\u00e9s non classables \u00e0 diff\u00e9renciation TFH: \u00e0 propos de six cas illustrant de nouveaux aspects anatomocliniques. Ann. Dermatol. V\u00e9n\u00e9r\u00e9ologie 139, B70\u2013B71 (2012).","journal-title":"Ann. Dermatol. V\u00e9n\u00e9r\u00e9ologie"},{"key":"33031_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/archdermatol.2011.3269","volume":"148","author":"M Battistella","year":"2012","unstructured":"Battistella, M. et al. Primary cutaneous follicular helper T-cell lymphoma: A new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases. Arch. Dermatol. 148, 832\u2013839 (2012).","journal-title":"Arch. Dermatol."},{"key":"33031_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/modpathol.2008.40","volume":"21","author":"KL Grogg","year":"2008","unstructured":"Grogg, K. L., Jung, S., Erickson, L. A., McClure, R. F. & Dogan, A. Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: A clonal T-cell lymphoproliferative disorder with indolent behavior. Mod. Pathol. 21, 708\u2013715 (2008).","journal-title":"Mod. Pathol."},{"key":"33031_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/DAD.0000000000000266","volume":"37","author":"B Kaffenberger","year":"2015","unstructured":"Kaffenberger, B. et al. Extranodal marginal zone lymphoma-like presentations of angioimmunoblastic T-cell lymphoma: A T-cell lymphoma masquerading as a B-cell lymphoproliferative disorder. Am. J. Dermatopathol. 37, 604\u2013613 (2015).","journal-title":"Am. J. Dermatopathol."},{"key":"33031_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/DAD.0b013e3182a72f8c","volume":"36","author":"J-H Park","year":"2014","unstructured":"Park, J.-H., Han, J. H., Kang, H. Y., Lee, E.-S. & Kim, Y. C. Expression of follicular helper T-cell markers in primary cutaneous T-cell lymphoma. Am. J. Dermatopathol. 36, 465\u2013470 (2014).","journal-title":"Am. J. Dermatopathol."},{"key":"33031_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/PAS.0000000000001984","volume":"47","author":"IE Obiorah","year":"2023","unstructured":"Obiorah, I. E. et al. Overlapping features of primary cutaneous marginal zone lymphoproliferative disorder and primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder: A diagnostic challenge examined by genomic analysis. Am. J. Surg. Pathol. 47, 344\u2013353 (2023).","journal-title":"Am. J. Surg. Pathol."},{"key":"33031_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17395","author":"C Bommier","year":"2021","unstructured":"Bommier, C. et al. Real-life targeted next-generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network. Br. J. Haematol. https:\/\/doi.org\/10.1111\/bjh.17395 (2021).","journal-title":"Br. J. Haematol."},{"key":"33031_CR12","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","volume":"128","author":"D Vallois","year":"2016","unstructured":"Vallois, D. et al. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell\u2013derived lymphomas. Blood 128, 1490\u20131502 (2016).","journal-title":"Blood"},{"key":"33031_CR13","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba, S. & Sakata-Yanagimoto, M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia 34, 2592\u20132606 (2020).","journal-title":"Leukemia"},{"key":"33031_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","volume":"32","author":"J Steinhilber","year":"2019","unstructured":"Steinhilber, J. et al. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations. Mod. Pathol. 32, 1123\u20131134 (2019).","journal-title":"Mod. Pathol."},{"key":"33031_CR15","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","volume":"123","author":"O Odejide","year":"2014","unstructured":"Odejide, O. et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123, 1293\u20131296 (2014).","journal-title":"Blood"},{"key":"33031_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/cas.13393","volume":"109","author":"K Fukumoto","year":"2018","unstructured":"Fukumoto, K., Nguyen, T. B., Chiba, S. & Sakata-Yanagimoto, M. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma. Cancer Sci. 109, 490\u2013496 (2018).","journal-title":"Cancer Sci."},{"key":"33031_CR17","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/PAS.0000000000000956","volume":"41","author":"A LeclaireAlirkilicarslan","year":"2017","unstructured":"LeclaireAlirkilicarslan, A. et al. Expression of TFH markers and detection of RHOA pG17V and IDH2 pR172K\/S mutations in cutaneous localizations of angioimmunoblastic T-cell lymphomas. Am. J. Surg. Pathol. 41, 1581\u20131592 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"33031_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001470","author":"F Beltzung","year":"2020","unstructured":"Beltzung, F. et al. Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorders: A clinical, pathologic, and molecular study of 60 cases presenting with a single lesion. Am. J. Surg. Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000001470 (2020).","journal-title":"Am. J. Surg. Pathol."},{"key":"33031_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14730","author":"C Bergqvist","year":"2021","unstructured":"Bergqvist, C. et al. Lymphomatoid papulosis types D and E: A multicentre series of the French Cutaneous Lymphomas Study Group. Clin. Exp. Dermatol. https:\/\/doi.org\/10.1111\/ced.14730 (2021).","journal-title":"Clin. Exp. Dermatol."},{"key":"33031_CR20","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/bjd.17834","volume":"181","author":"L Dequidt","year":"2019","unstructured":"Dequidt, L. et al. Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database. Br. J. Dermatol. 181, 616\u2013618 (2019).","journal-title":"Br. J. Dermatol."},{"key":"33031_CR21","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","volume":"35","author":"C Laurent","year":"2017","unstructured":"Laurent, C. et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 35, 2008\u20132017 (2017).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"33031_CR22","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen, J. J. M. et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17, 2257\u20132317 (2003).","journal-title":"Leukemia"},{"key":"33031_CR23","doi-asserted-by":"crossref","unstructured":"Trecourt, A. et al. Plasticity of mature B cells between follicular and classic hodgkin lymphomas: A series of 22 cases expanding the spectrum of transdifferentiation. Am. J. Surg. Pathol. Publish Ahead of Print, (2021).","DOI":"10.1097\/PAS.0000000000001780"},{"key":"33031_CR24","unstructured":"Medistica. pvalue.io, a Graphic User Interface to the R statistical analysis software for scientific medical publications https:\/\/www.pvalue.io\/fr (2020) ."},{"key":"33031_CR25","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","volume":"34","author":"JT Edinger","year":"2010","unstructured":"Edinger, J. T., Kant, J. A. & Swerdlow, S. H. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am. J. Surg. Pathol. 34, 1830\u20131841 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"33031_CR26","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/ajcp\/aqaa116","volume":"154","author":"SE Gibson","year":"2020","unstructured":"Gibson, S. E. & Swerdlow, S. H. How I diagnose primary cutaneous marginal zone lymphoma. Am. J. Clin. Pathol. 154, 428\u2013449 (2020).","journal-title":"Am. J. Clin. Pathol."},{"key":"33031_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15372","author":"H Shi","year":"2020","unstructured":"Shi, H. et al. Clinicopathological analysis of primary cutaneous CD4-positive small\/medium pleomorphic T-cell lymphoproliferative disorder: A retrospective study of 22 patients. Int. J. Dermatol. https:\/\/doi.org\/10.1111\/ijd.15372 (2020).","journal-title":"Int. J. Dermatol."},{"key":"33031_CR28","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.3324\/haematol.2018.214957","volume":"104","author":"L Cascione","year":"2019","unstructured":"Cascione, L. et al. Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses. Haematologica 104, e558\u2013e561 (2019).","journal-title":"Haematologica"},{"key":"33031_CR29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"V Spina","year":"2016","unstructured":"Spina, V. et al. The genetics of nodal marginal zone lymphoma. Blood 128, 1362\u20131373 (2016).","journal-title":"Blood"},{"key":"33031_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/aol-20-38","volume":"5","author":"V Spina","year":"2021","unstructured":"Spina, V., Mensah, A. A. & Arribas, A. J. Biology of splenic and nodal marginal zone lymphomas. Ann. Lymphoma 5, 6\u20136 (2021).","journal-title":"Ann. Lymphoma"},{"key":"33031_CR31","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11264","author":"Q Zhu","year":"2020","unstructured":"Zhu, Q. et al. FBW7 in hematological tumors (review). Oncol. Lett. https:\/\/doi.org\/10.3892\/ol.2020.11264 (2020).","journal-title":"Oncol. Lett."},{"key":"33031_CR32","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","volume":"138","author":"K Maurus","year":"2018","unstructured":"Maurus, K. et al. Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. J. Investig. Dermatol. 138, 1573\u20131581 (2018).","journal-title":"J. Investig. Dermatol."},{"key":"33031_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.trecan.2015.10.006","volume":"1","author":"MA Jacoby","year":"2015","unstructured":"Jacoby, M. A., Duncavage, E. J. & Walter, M. J. Implications of tumor clonal heterogeneity in the era of next-generation sequencing. Trends Cancer 1, 231\u2013241 (2015).","journal-title":"Trends Cancer"},{"key":"33031_CR34","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","volume":"33","author":"Y Watatani","year":"2019","unstructured":"Watatani, Y. et al. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia 33, 2867\u20132883 (2019).","journal-title":"Leukemia"},{"key":"33031_CR35","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: The catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"33031_CR36","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos, C. et al. VarSome: The human genomic variant search engine. Bioinformatics 35, 1978\u20131980 (2019).","journal-title":"Bioinformatics"},{"key":"33031_CR37","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/gcc.22679","volume":"57","author":"AN Bastidas Torres","year":"2018","unstructured":"Bastidas Torres, A. N. et al. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides. Genes. Chromosomes Cancer 57, 653\u2013664 (2018).","journal-title":"Genes. Chromosomes Cancer"},{"key":"33031_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/modpathol.2012.124","volume":"26","author":"HJ Meyerson","year":"2013","unstructured":"Meyerson, H. J. et al. Follicular center helper T-cell (TFH) marker positive mycosis fungoides\/Sezary syndrome. Mod. Pathol. 26, 32\u201343 (2013).","journal-title":"Mod. Pathol."},{"key":"33031_CR39","unstructured":"Follicular center helper T-cell (TFH) marker positive mycosis fungoides\/Sezary syndrome|Modern Pathology. https:\/\/www.nature.com\/articles\/modpathol2012124?draft=collection."},{"key":"33031_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25\u201338 (2011).","journal-title":"Cancer Cell"},{"key":"33031_CR41","doi-asserted-by":"publisher","first-page":"623948","DOI":"10.3389\/fcell.2020.623948","volume":"8","author":"NJ Tsiouplis","year":"2021","unstructured":"Tsiouplis, N. J., Bailey, D. W., Chiou, L. F., Wissink, F. J. & Tsagaratou, A. TET-mediated epigenetic regulation in immune cell development and disease. Front. Cell Dev. Biol. 8, 623948 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"33031_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","volume":"33","author":"JR Cortes","year":"2018","unstructured":"Cortes, J. R. et al. RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis. Cancer Cell 33, 259-273.e7 (2018).","journal-title":"Cancer Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33031-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33031-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T18:29:53Z","timestamp":1682015393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33031-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33031"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33031-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6500"}}